Evidence map›Paper›PMID 36313665›Full record

ArticleFrontiers in oncology2022

Multilevel impacts of a pediatric early warning system in resource-limited pediatric oncology hospitals.

Emily Mirochnick, Dylan E Graetz, Gia Ferrara, Maria Puerto-Torres, Srinithya R Gillipelli, Paul Elish, Hilmarie Muniz-Talavera, Alejandra Gonzalez-Ruiz, Miriam Armenta, Camila Barra and 9 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Emily MirochnickThe Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States.
Dylan E GraetzDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Gia FerraraDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Maria Puerto-TorresDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Srinithya R GillipelliDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Paul ElishRollins School of Public Health, Emory University, Atlanta, GA, United States.
Hilmarie Muniz-TalaveraDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Alejandra Gonzalez-RuizDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Miriam ArmentaPediatric Oncology, Hospital General de Tijuana, Tijuana, Mexico.
Camila BarraPediatric Oncology, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.
Rosdali Diaz-CoronadoPediatric Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Cinthia HernandezPediatric Oncology, Hospital Infantil Teletón de Oncología, Querétaro, Mexico.
Susana JuarezPediatrics, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico.
Jose de Jesus LoezaPediatric Oncology, Centro Estatal de Cancerología, Xalapa, Mexico.
Alejandra MendezPediatric Critical Care, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
Erika MontalvoPediatric Critical Care, Hospital Oncológico Solca Núcleo de Quito, Quito, Ecuador.
Eulalia PenafielPediatric Oncology, Instituto del Cáncer Solca Cuenca, Cuenca, Ecuador.
Estuardo PinedaPediatric Oncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador.
Asya AgulnikDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.

Funding

PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
NCI NIH HHS R25 CA023944
6 · The paper itself

Abstract

Background: Pediatric Early Warning Systems (PEWS) reduce clinical deterioration, improve interdisciplinary communication, and provide cost savings; however, little is known about how these impacts are achieved or related. This study evaluates the multi-level impacts of PEWS in resource-limited pediatric oncology centers. Methods: We conducted 71 semi-structured interviews including physicians (45%), nurses (45%), and administrators (10%) from 5 resource-limited pediatric oncology centers in 4 Latin American countries. Interviews were conducted in Spanish, transcribed, and translated into English. A code book was developed using Results: PEWS improved the quality of attention for Conclusions: In resource-limited hospitals, PEWS use results in multi-level positive impacts on

Indexed as

global healthLatin Americapediatric critical carePediatric Early Warning System (PEWS)pediatric oncologyquality improvementresource-limited

Identifiers

PMID36313665
PMCPMC9597682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.